Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Admission (1)
- Biotechnology (1)
- Blockchain (1)
- Commodities (1)
- Corporations (1)
-
- Cryptocurrency (1)
- Currency (1)
- Discretion (1)
- Drugs (1)
- Federal Rules of Evidence (1)
- Forensic evidence (1)
- Incentives (1)
- Initial coin offerings (1)
- Law reform (1)
- Medicine (1)
- Microbes (1)
- Microbiomes (1)
- Patent law (1)
- Patent protection (1)
- Patentability (1)
- Pharmaceuticals (1)
- Regulation (1)
- Relevance (1)
- Reliability (1)
- Research and development (1)
- SEC v. W. J. Howey Co. (1)
- Scientific evidence (1)
- Securities (1)
- Securities and Exchange Commission (1)
- Technology (1)
Articles 1 - 3 of 3
Full-Text Articles in Law
Cabining Judicial Discretion Over Forensic Evidence With A New Special Relevance Rule, Emma F.E. Shoucair
Cabining Judicial Discretion Over Forensic Evidence With A New Special Relevance Rule, Emma F.E. Shoucair
Michigan Law Review
Modern forensic evidence suffers from a number of flaws, including insufficient scientific grounding, exaggerated testimony, lack of uniform best practices, and an inefficacious standard for admission that regularly allows judges to admit scientifically unsound evidence. This Note discusses these problems, lays out the current landscape of forensic science reform, and suggests the addition of a new special relevance rule to the Federal Rules of Evidence (and similar rules in state evidence codes). This proposed rule would cabin judicial discretion to admit non-DNA forensic evidence by barring prosecutorial introduction of such evidence in criminal trials absent a competing defense expert or …
The Uneasy Case For Patent Law, Rachel E. Sachs
The Uneasy Case For Patent Law, Rachel E. Sachs
Michigan Law Review
A central tenet of patent law scholarship holds that if any scientific field truly needs patents to stimulate progress, it is pharmaceuticals. Patents are thought to be critical in encouraging pharmaceutical companies to develop and commercialize new therapies, due to the high costs of researching diseases, developing treatments, and bringing drugs through the complex, expensive approval process. Scholars and policymakers often point to patent law’s apparent success in the pharmaceutical industry to justify broader calls for more expansive patent rights.
This Article challenges this conventional wisdom about the centrality of patents to drug development by presenting a case study of …
The Commodification Of Cryptocurrency, Neil Tiwari
The Commodification Of Cryptocurrency, Neil Tiwari
Michigan Law Review
Cryptocurrencies are digital tokens built on blockchain technology. This allows for a product that is fully decentralized, with no need for a third-party intermediary like a government or financial institution. Cryptocurrency creators use initial coin offerings (ICOs) to raise capital to build their tokens. Cryptocurrency ICOs are problematic because they do not fit neatly within either of two traditional categories—securities or commodities. Each of these categories has their own regulatory agency: the SEC for securities and the CFTC for commodities. At first blush, ICOs seem to be a sale of securities subject to regulation by the SEC, but this is …